RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Genk Capital vs MiFunder

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

GENK

Genk Capital

EST. 2010

MIFD

MiFunder

GENK CAPITAL

METRIC

MIFUNDER

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

GENK CAPITAL DETAILS

STEPS: -phase
MARKETS: Equities, Commodities, Digital Assets

MIFUNDER DETAILS

STEPS: -phase

Genk Capital PROS

+Founded in 2010, giving Genk Capital over 14 years of operational history and implied institutional experience.
+Singapore-based firm operating in one of Asia's most reputable and well-regulated financial hubs.
+Covers Equities, Commodities, and Digital Assets, offering access to diverse and distinct asset classes.
+Long-established presence may suggest greater financial stability than newer prop firms.

Genk Capital CONS

−No profit split, max funding, drawdown, or challenge cost data is available for industry comparison.
−Absence of platform information makes it impossible to assess the trading environment.
−Traders cannot evaluate value or risk parameters without core metrics such as drawdown or profit targets.

MiFunder PROS

+No data is available to identify any pros for MiFunder at this time.
+No platform or market information is provided to assess trading conditions.
+No funding or cost data is available to compare against industry benchmarks.
+No profit split or payout data exists to evaluate trader compensation.

MiFunder CONS

−No data whatsoever is available for MiFunder, making any evaluation impossible.
−Complete absence of key metrics such as drawdown, profit split, and funding is a significant transparency concern.
−Traders have no basis for comparison against industry averages with zero data disclosed.

PROPDNA VERDICT